Development status of clinical pathway at home and abroad
10.3760/cma.j.cn111325-20230411-00287
- VernacularTitle:临床路径的国内外发展现状分析
- Author:
Shuzhen PENG
1
;
Ye YI
;
Kewen LIN
;
Jia′ao LOU
;
Yibei SI
;
Yinghui JIN
;
Jiajia FENG
;
Pan ZHANG
;
Likai LIN
Author Information
1. 武汉大学医学部，武汉 430071
- Keywords:
Practice management, medical;
Clinical pathway;
Medical quality management;
Current situation at home and abroad;
Reform of medical insurance payment meth
- From:
Chinese Journal of Hospital Administration
2023;39(8):569-574
- CountryChina
- Language:Chinese
-
Abstract:
Clinical pathway is an important quality management tool for regulating medical behavior both at home and abroad, and an important means of controlling medical costs in the reform of medical insurance payment methods.The author reviewed the current development status of clinical pathways both at home and abroad, focusing on summarizing the development experience of foreign countries, and analyzing the shortcomings in the development of clinical pathways in China from the perspectives of formulation, implementation, and evaluation. It is proposed that China should establish and improve the regulatory and incentive mechanisms for clinical pathways, accelerate the construction of supporting medical security systems, explore new incentive transmission models, attach importance to the role of patient participation in the formulation and implementation of clinical pathways, and so on, in order to provide reference for promoting the efficient development of clinical pathways in China.
